Epogen, Procrit May Increase Heart Attack Damage: Study
The findings of recent research suggest that using the anemia drugs Epogen and Procrit following a heart attack is not only ineffective, but may cause further heart damage.
Tag Archives: Epoetin Alfa
-
-
Use of Anemia Drugs for Kidney Failure Supported by FDA Panel
Despite a potential risk of stroke associated with the use of Aranesp, Procrit and Epogen, an FDA advisory panel has indicated that the anemia drugs are safe to use to…
-
Procrit and Epogen Recall Issued Over Glass Flakes in Vials
A recall of Epogen and Procrit vials has been issued due to a risk that certain lots of the anemia drugs may be contaminated with small glass flakes that could…
-
Anemia Drugs Increase Risk of Heart Problems, Death in Some Cases: Study
The findings of a new study indicate that people with chronic kidney disease and diabetes who respond poorly to certain anemia drugs may face an increased risk of cardiovascular problems…
-
Aranesp, Epogen and Procrit Blood Clot Risk Confirmed: Study
According to new research, the anti-anemia drugs Aranesp, Epogen and Procrit not only increase the risk of blood clots, but they also do not appear to be doing what they…
-
Aranesp Increases Risk of Stroke for Some Patients: Study
New research suggests that side effects of Aranesp, an anemia drug, could increase the risk of stroke in some patients.
-
FDA Reviewing Epogen and Procrit Side Effects After Study Identifies Risk of Death
The FDA has issued an “Early Communication” about their ongoing safety review of a potential increased risk of death associated with Procrit and Epogen, which are used to treat anemia.
